Form 4: Amgen CEO Exercises Options, Adjusts Holdings

Amgen's Chairman, CEO, and President, Robert A. Bradway, exercised stock options and adjusted his direct common stock holdings.

Summary

• Robert A. Bradway, Amgen's Chairman, CEO, and President, exercised 119,782 non-qualified stock options on March 4, 2026, at an exercise price of $156.35 per share.
• Following the option exercise, 84,285 shares of common stock were disposed of at a price of $379.27 per share to cover the option exercise price and tax withholding obligations.
• As a result of these transactions, Bradway's direct beneficial ownership of Amgen common stock is 492,643 shares.
• He also maintains indirect beneficial ownership of 90,000 shares through a GRAT and an additional 90,000 shares through a Spousal GRAT.
• The reported direct shares include 2,414 Dividend Equivalents (DEs) granted under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan, which are paid out in shares of common stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a routine insider transaction where the CEO exercised options and covered tax obligations. The exercise itself is a neutral to slightly positive signal, indicating the options were in-the-money and value was realized.

Positives

• The exercise of 119,782 stock options indicates the realization of value from long-term incentives, with an exercise price of $156.35 significantly below the $379.27 price at which shares were withheld for tax, suggesting a substantial in-the-money value.
• The net effect of the transactions is an increase in direct beneficial ownership by 35,497 shares (119,782 acquired minus 84,285 disposed for tax/exercise).

Negatives

• A significant portion of the acquired shares (84,285 shares) were immediately disposed of to cover tax liabilities and the option exercise price, reducing the net increase in direct beneficial ownership.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly by top executives like a CEO, are closely watched indicators of management's perspective on the company's valuation and future prospects. While option exercises often involve tax-related sales, the underlying decision to exercise can reflect a belief in the stock's current strength or a strategic move within a pre-planned trading arrangement.

Stakeholder Impact

• Shareholders: Provides transparency into executive stock ownership and transactions, which can influence investor sentiment.

Key Dates

Recommendation

This Form 4 reports a routine exercise of stock options by the CEO, which included a sale of shares to cover taxes and the exercise price. Such transactions are common and do not typically signal a change in the company's fundamental outlook or warrant a strong buy/sell recommendation. Investors should view this as a standard compensation-related event rather than a strong indicator of future stock performance.

Keywords

Amgen, AMGN, Robert Bradway, SEC Form 4, Stock Options, Insider Trading, Equity Incentive Plan, CEO, Director, Common Stock, Dividend Equivalents